There is an increase in the number of patients suffering from chronic pain. According to the 2019 National Health Interview Survey (NHIS), the prevalence of chronic pain in US Adults was 20.4%, with high-impact chronic pain accounting for 7.4%. The incidence of chronic pain was the highest among people aged 65 and above (30.8%), non-Hispanic white adults (23.6%), and women (21.7%). High impact chronic pain was highest among people aged 65 and above (11.8%) and women (8.5%). Medical photobiostimulating systems are used to reduce pain, inflammation, and edema; promote the healing of wounds, deeper tissue, and nerves; and prevent tissue damage. Therefore, the surging number of patients suffering from chronic pain and other chronic illness is driving the North America medical photobiostimulation system market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the medical photobiostimulation system market at a promising CAGR during the forecast period.
The North America medical photobiostimulation system market is segmented into product and application. Based on product, the market is segmented into infrared light, red light, and others. Based on application, the market is segmented into pain management, wound care, cosmetic applications, and others. Geographically, the North America medical photobiostimulation system market is segmented into the US, Canada, and Mexico.
BioLight Technologies LLC., Omega Laser Systems Ltd, Vielight Inc., Theradome Inc., Lexington Intl., LLC, THOR Photomedicine Ltd, iRestore Hair Growth System, Meditech International Inc. (BIOFLEX Laser Therapy), and Apira Science, Inc. (iGrow Laser) are among the leading companies in the North America medical photobiostimulation system market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 89.4 Million |
| Market Size by 2028 | US$ 139.6 Million |
| CAGR (2021 - 2028) | 6.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Medical Photobiostimulation System Market is valued at US$ 89.4 Million in 2021, it is projected to reach US$ 139.6 Million by 2028.
As per our report North America Medical Photobiostimulation System Market, the market size is valued at US$ 89.4 Million in 2021, projecting it to reach US$ 139.6 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Medical Photobiostimulation System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Photobiostimulation System Market report:
The North America Medical Photobiostimulation System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Photobiostimulation System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Photobiostimulation System Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Medical Photobiostimulation System Market
